Market Place
Sourcing Support
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
FDA haunted by problems at Chinese plant; Sun Pharma gets entangled in price gouging furor
Phispers brings you the latest in global pharma
news, such as how the drug price hike uproar in the
